Skip to main content

Table 4 Comparison of changes in total and HMW adiponectin between non-responders, moderate responders and good responders (EULAR definition) at each time point (results are given as mean ± SD; N number of subjects; P#: Kruskal Wallis test. Results of post hoc analysis [Dwass-Steel-Crichtlow-Fligner test] for total adiponectin at M1: moderate versus good responders: p = 0.0482; non-responders versus good responders: p = 0.974)

From: Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

  Adiponectin (훍g/mL) Non-responders Moderate responders Good responders P#
M1 Total 0.28 ± 3.4 (28) 2.41 ± 3.2 (41) 0.15 ± 3.8 (24) 0.012
HMW 0.53 ± 1.6 (27) 1.49 ± 3 (41) 0.82 ± 1.7 (24) 0.6
M3 Total 1.55 ± 3.4 (15) 1.9 ± 5.7 (31) 0.78 ± 4.3 (44) 0.9
HMW 1.55 ± 3.4 (15) 1.9 ± 5.7 (31) 0.78 ± 4.3 (44) 0.9
M6 Total − 0.87 ± 2.9 (17) 1.9 ± 3.3 (15) 1.17 ± 4.7 (52 0.078
HMW − 0.87 ± 2.9 (17) 1.9 ± 3.3 (15) 1.17 ± 4.7 (52 0.078
M12 Total 3.1 ± 6.9 (4) - 0.06 ± 4.5 (14) 0.77 ± 5.1 (46) 0.48
HMW 0.78 ± 1.9 (4) - 0.05 ± 2.1 (14) 0.53 ± 1.6 (47) 0.42
\